In Brief: FDA Science Board
Executive Summary
FDA Science Board: Will hear presentations on the Biomaterials Forum, FDA Information Retrieval System, activities of the Science Board Subcommittee on Toxicology and status of FDA implementation of recommendations from the board's Subcommittee on FDA Research at an open meeting Sept. 30. The session will begin at 9:30 a.m. at the Washington (D.C.) Plaza Hotel. Earlier in the morning, the board will meet in closed session to select recipients of the 1997 FDA Scientific Achievement Awards...